Healthcare & Life Sciences
Scancell
United Kingdomwww.scancell.co.uk
Scancell is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Scancell
Scancell is a company headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Scancell is a clinical-stage biotechnology company developing active immunotherapies for cancer treatment, focusing on its ImmunoBody and Moditope platforms to generate tumor-specific immunity.
Explore Scancell's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.